Integra LifeSciences has released of a smaller size of its Accell Evo3 Demineralized Bone Matrix, according to a release from Integra LifeSciences.
Originally introduced as a bone void filler for large orthopedic reconstructive procedures, the new smaller size can be used where smaller amounts of demineralized bone matrix are required.
Read Integra LifeSciences’ release on its Accell Evo3 Demineralized Bone Matrix.
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.